Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.64 |
| ▸ | CCR2 | P41597 | 4/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.55 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenpiprane SCHEMBL24507 | 1.00 | ALDH1A1 (0.66) | ALDH1A1KCNA3CCR2CYP2D6OPRL1 | |
| Fenpiprane SCHEMBL11585426 | 0.98 | ALDH1A1 (0.64) | ALDH1A1KCNA3CCR2CYP2D6OPRL1 | |
| Prozapine SCHEMBL365642 | 0.98 | ALDH1A1 (0.64) | ALDH1A1KCNA3CCR2CYP2D6OPRL1 | |
| SCHEMBL67164 | 0.89 | SIGMAR1 (0.66) | ALDH1A1SIGMAR1CACNA1B | |
| Hydrochloric Acid SCHEMBL29267226 | 0.88 | CYP3A4 (0.66) | ALDH1A1KCNA3CCR2CYP2D6OPRL1 | |
| Hydrochloric Acid SCHEMBL30517299 | 0.88 | CYP3A4 (0.66) | ALDH1A1KCNA3CCR2CYP2D6OPRL1 | |
| Diisopromine SCHEMBL28142824 | 0.84 | ALDH1A1 (0.51) | ALDH1A1KCNA3CCR2CYP2D6OPRL1 | |
| SCHEMBL5757757 | 0.83 | ALDH1A1 (0.53) | ALDH1A1KCNA3CCR2CYP2D6SIGMAR1 | |
| SCHEMBL7547846 | 0.83 | HTR1A (0.61) | SLC6A3 | |
| SCHEMBL6009479 | 0.83 | ALDH1A1 (0.53) | ALDH1A1KCNA3CCR2CYP2D6SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| CN-101203250-B | Methods and compositions for the delivery of biologically active agents via non-covalent interaction, and formed articles | INTERFACE BIOLOGICS INC | 2013-03-20 | — | — | CN | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1879578-A4 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2009-05-13 | — | — | EP | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| CN-101203250-A | Methods and compositions for the delivery of biologically active agents | INTERFACE BIOLOGICS INC (CA) | 2008-06-18 | — | — | CN | claimed |
| EP-1879578-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV Pharmaceutical Inc. (US) | 2008-01-23 | — | — | EP | claimed |
| EP-1868664-A2 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | Interface Biologics Inc. (CA) | 2007-12-26 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-2007019880-A1 | USE OF A SELECTIVE INHIBITOR OF NOREPINEPHRINE REUPTAKE FOR TREATING RESPIRATORY DISORDERS RESULTING FROM RETT SYNDROME | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2007-02-22 | — | — | WO | claimed |
| US-20070037891-A1 | Methods and compositions for the delivery of biologically active agents | INTERFACE BIOLOGICS (CA) | 2007-02-15 | — | — | US | claimed |
| WO-2007004067-A2 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | INTERFACE BIOLOGICS INC. (CA) | 2007-01-11 | — | — | WO | claimed |
| WO-2006102029-A9 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2006-12-07 | — | — | WO | claimed |
| WO-2006102029-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL, INC. (US) | 2006-09-28 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-4168092-B1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | BARD INC C R (US) | 2026-05-27 | — | — | EP | disclosed |
| US-4086234-A | Process for the preparation of tertiary amines | G. D. SEARLE & CO. (US) | 1978-04-25 | — | — | US | disclosed |